Types of Cancer
Artificial Intelligence Boosts Breast Tumor Detection Rates in Mammography Screening: Findings from a Swedish Study
Artificial intelligence (AI)-assisted mammography screening is safe and improves detection of breast tumors responsible for breast cancer. Millions of women undergo mammography screenings every year in the US. This …
Clinical Evaluation of Self-Replicating RNA and Anti-PD-1 Antibody in Advanced HER2+ Breast Cancer
In an effort to stimulate T cell and antibody responses against tumor-expressed antigens, numerous platforms like proteins, peptides, viral vectors, DNA plasmids, and RNA have been modified for use …
Osimertinib: A Potential Game-Changer in the Battle Against Lung Cancer
In the rapidly evolving arena of oncology, a novel drug, osimertinib, has surfaced as a potential lifesaver for patients battling a specific type of lung cancer. This breakthrough, unveiled …
Unraveling the Complexities of Stomach Cancer: An Extensive Examination of Its Causes, Symptoms, Risk Factors, and Modern Treatment Approaches
Stomach cancer, also called gastric carcinoma, develops from an initially normal parietal cell (cell in the lining of the stomach) that multiplies uncontrollably and forms a mass called a …
UV Lamp Manicures: The Surprising Risk That Could Lead to Skin Cancer
It is well known that manicures and pedicures are very popular among both women and men for aesthetic and practical reasons. However, in a recently done study it was …
Brain Cancer: Transmembrane Form of tmCLIC1 Responsible for Glioblastoma Proliferation
Glioblastoma (GB) is a kind of brain cancer. Previously known as glioblastoma multiforme, it is one of the most deadly types of cancer that starts in the brain. Being …Relationship between Breast Cancer Spread and Class II MHC revealed
Cancer has become a global problem over the years. Roughly 10 million deaths, or close to one in six deaths, were caused by cancer in 2020, making it the …
Inhibiting the Enzyme G6PD Destroys Metastatic Ovarian Cancer Cells in the Omentum
A team from the Los Angeles-based Terasaki Institute for Biomedical Innovation has identified the key role of a metabolic enzyme in ovarian cancer metastasis. The enzyme, glucose-6-phosphate dehydrogenase (G6PD), …